Dream CIS Co. Ltd. (223250)

Overview

DreamCIS, Inc. is a prominent clinical research service provider based in Seoul, South Korea. Since its inception in 2000, the company has carved out a significant niche in the clinical research industry within the country. DreamCIS, Inc. extends a comprehensive suite of clinical development and regulatory consulting services tailored for the biomedical sector. Its extensive range of offerings caters to various phases of clinical trials and biomedical product development, ensuring adherence to regulatory standards and fostering advancements in medical research.

Products and Services

• Clinical Development Services - DreamCIS, Inc. provides full-scale clinical development services, encompassing the design and execution of clinical trials for new drugs and medical devices. These services ensure that new therapeutics are tested for efficacy and safety in compliance with international standards.
• Biostatistics, Data, and Project Management - The company offers comprehensive data management and analysis services, including biostatistics, ensuring the integrity and confidentiality of trial data. Project management services ensure that clinical trials are executed efficiently, on time, and within budget.
• Pharmacovigilance - Pharmacovigilance services are aimed at monitoring and evaluating the safety profiles of pharmaceutical products, ensuring any adverse effects are promptly identified, assessed, and managed.
• Medical Writing - This service entails the creation of scientific documentation related to clinical trials, including protocol development, consent forms, and final study reports, adhering to regulatory requirements and industry standards.
• Site Start-up - DreamCIS, Inc. assists in the initial setup and preparation of clinical trial sites, ensuring they are fully equipped and compliant with study protocols and regulations.
• Clinical Monitoring - Clinical monitoring services are offered to oversee the conduct of clinical trials, ensuring compliance with the protocol and regulatory requirements, thus safeguarding the integrity of the study and the well-being of participants.
• Dreamtrial - Dreamtrial is a proprietary service or technology platform, presumably designed to streamline and enhance the clinical trial process, although specifics are not detailed in the provided information.
• IWRS - Interactive Web Response Systems (IWRS) are utilized by DreamCIS to manage patient enrollment, randomization, and drug supply management, enhancing the efficiency and accuracy of clinical trial operations.
• Quality Assurance Services - These services are dedicated to ensuring that all aspects of clinical research are conducted in accordance with Good Clinical Practice (GCP) standards, national and international regulations, and customer quality requirements.
• Medical Device Development Services - DreamCIS, Inc. provides specialized services for the development and testing of medical devices, from conception through to regulatory approval, ensuring innovative medical technologies meet the required safety and efficacy standards.
• Regulatory Consulting Services - The company offers consultation on regulatory strategies and submissions, helping clients navigate the complexities of regulatory requirements to achieve successful market authorizations for their products.